The potential mechanisms underlying sPD-L1’s prognostic value for DLBCL are as follows: First, sPD-L1 can reduce cyclin A, ERK (p-ERK), and Akt; reduce adenosine triphosphate production; and attenuate T-cell respiration (22). The gene discussed is AKT1; the disease is diffuse large B-cell lymphoma.